HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David M Pariser Selected Research

Pilocarpine (Ocusert)

2/2017Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David M Pariser Research Topics

Disease

31Psoriasis (Pustulosis Palmaris et Plantaris)
03/2023 - 04/2003
12Hyperhidrosis
01/2021 - 05/2007
11Acne Vulgaris
01/2022 - 08/2005
8Onychomycosis (Tinea Unguium)
07/2021 - 04/2013
7Actinic Keratosis
12/2023 - 02/2003
6Erythema
03/2023 - 11/2003
3Basal Cell Carcinoma (Rodent Ulcer)
10/2021 - 02/2006
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2023 - 11/2019
2Nasopharyngitis
01/2023 - 11/2019
2Body Weight (Weight, Body)
01/2023 - 05/2016
2Atopic Dermatitis (Atopic Eczema)
06/2022 - 08/2005
2Infections
02/2018 - 06/2015
2Neoplasms (Cancer)
08/2012 - 11/2009
2Rosacea (Acne Rosacea)
02/2006 - 11/2003
1Seborrheic Dermatitis
01/2023
1Inflammation (Inflammations)
01/2023
1Oral Candidiasis (Thrush)
01/2023
1Allergic Rhinitis
06/2022
1Asthma (Bronchial Asthma)
06/2022
1Bowen's Disease (Disease, Bowen)
10/2021
1Skin Neoplasms (Skin Cancer)
10/2021
1Melanoma (Melanoma, Malignant)
10/2021
1Pruritus (Itching)
06/2020
1Headache (Headaches)
11/2019
1Dizziness (Lightheadedness)
11/2019
1Phototoxic Dermatitis (Phototoxicity)
11/2019
1Nausea
11/2019
1Vomiting
11/2019
1Diarrhea
11/2019
1Sunburn
11/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2016
1Psoriatic Arthritis
05/2016
1Hypotrichosis
07/2015

Drug/Important Bio-Agent (IBA)

7Immunoglobulin A (IgA)IBA
03/2023 - 12/2016
6Cholinergic Antagonists (Anticholinergics)IBA
01/2021 - 02/2017
6glycopyrronium tosylateIBA
01/2021 - 01/2019
5RoflumilastIBA
03/2023 - 01/2022
5Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 03/2017
51-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2021 - 02/2003
5halobetasol (ulobetasol)FDA LinkGeneric
01/2019 - 03/2017
5tazarotene (Tazorac)FDA Link
01/2019 - 03/2017
4Adapalene (Differin)FDA LinkGeneric
01/2022 - 08/2005
3Benzoyl PeroxideFDA LinkGeneric
01/2022 - 09/2007
3tavaboroleIBA
02/2018 - 06/2015
3efinaconazoleIBA
03/2016 - 04/2013
3efalizumab (Raptiva)FDA Link
01/2008 - 12/2005
2Aminolevulinic Acid (Levulan)FDA Link
12/2023 - 03/2016
2secukinumabIBA
01/2023 - 12/2019
2Interleukin-17 (Interleukin 17)IBA
01/2023 - 12/2019
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2019
2clindamycin phosphate (Clindets)FDA LinkGeneric
01/2022 - 09/2014
2SolutionsIBA
07/2021 - 04/2013
2Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2021 - 08/2019
2Infliximab (Remicade)FDA Link
01/2021 - 01/2008
2Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2020 - 10/2018
2apremilastIBA
07/2016 - 02/2013
2Etanercept (Enbrel)FDA Link
02/2016 - 08/2012
2Type A Botulinum Toxins (Botox)FDA Link
09/2015 - 05/2007
2Ciclopirox (Loprox)FDA LinkGeneric
06/2015 - 09/2003
2AntiperspirantsIBA
10/2014 - 10/2014
2Ointments (Pastes)IBA
04/2007 - 08/2005
1Biomarkers (Surrogate Marker)IBA
01/2023
1bimekizumabIBA
01/2023
1Adalimumab (Humira)FDA Link
01/2023
1dupilumabIBA
06/2022
1tildrakizumabIBA
05/2022
1Drug CombinationsIBA
01/2022
1GelsIBA
01/2022
1RetinoidsIBA
01/2022
1Phosphodiesterase 4 InhibitorsIBA
01/2022
1AcidsIBA
10/2021
1Terbinafine (Lamisil)FDA LinkGeneric
07/2021
1Ustekinumab (CNTO 1275)FDA Link
01/2021
1PF-06700841IBA
12/2020
1Neurokinin-1 Receptor AntagonistsIBA
06/2020
1serlopitantIBA
06/2020
1Midazolam (Versed)FDA LinkGeneric
12/2019
1Cytochrome P-450 CYP3AIBA
12/2019
1EnzymesIBA
12/2019
1sarecyclineIBA
11/2019
1Tetracycline (Achromycin)FDA LinkGeneric
11/2019
1Therapeutic UsesIBA
07/2018
13-ingenyl angelateIBA
05/2017
1Pilocarpine (Ocusert)FDA LinkGeneric
02/2017
1Muscarinic AntagonistsIBA
02/2017
1THVD-102IBA
02/2017
1oxybutynin (Tavor)FDA LinkGeneric
02/2017
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
07/2016
1Janus Kinase InhibitorsIBA
05/2016
1tofacitinibIBA
05/2016
1Bimatoprost (Lumigan)FDA Link
07/2015
1Ophthalmic Solutions (Eye Drops)IBA
07/2015
1AzolesIBA
06/2015
1BoronIBA
06/2015

Therapy/Procedure

19Therapeutics
06/2022 - 11/2003
5Photochemotherapy (Photodynamic Therapy)
12/2023 - 02/2003
3Biological Therapy
06/2022 - 04/2003
2Lasers (Laser)
03/2016 - 09/2015
2Injections
09/2015 - 10/2014
1Drug Therapy (Chemotherapy)
07/2015